First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Resource Type
Article
Authors
Zhong, Hua ; Sun, Shengjie ; Chen, Jianhua ; Wang, Ziping ; Zhao, Yanqiu ; Zhang, Guojun ; Chen, Gongyan ; Zhou, Ming ; Zhou, Jianying ; Du, Yingying ; Wu, Lin ; Xu, Zhi ; Mei, Xiaodong ; Zhang, Weidong ; He, Jingdong ; Cui, Jiuwei ; Zhang, Zhihong ; Luo, Hui ; Liu, Weiyou ; Sun, Meili ; Wu, Jingxun ; Shen, Yongchun ; Zhang, Shucai ; Yang, Nong ; Wang, Mengzhao ; Lu, Junguo ; Li, Kai ; Yao, Weirong ; Sun, Qian ; Yue, Hongmei ; Wang, Lin ; Ye, Sheng ; Li, Bin ; Zhuang, Xibin ; Pan, Yueyin ; Zhang, Min ; Shu, Yongqian ; He, Zhiyong ; Pan, Lei ; Ling, Yang ; Liu, Shengming ; Zhang, Qi ; Jiao, Shunchang ; Han, Baohui
Source
In The Lancet Respiratory Medicine May 2024 12(5):355-365
Subject
Primary Research Articles
Language
ISSN
2213-2600